Hanover - Delayed Quote • EUR CureVac NV (5CV.HA) Follow Compare 4.2460 +0.3440 +(8.82%) At close: January 10 at 5:25:11 PM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 5CV.HA 1D 5D 23.72% 1M 36.35% 3M 59.62% 6M 45.51% YTD 41.44% 1Y 10.14% 5Y -94.02% All -94.02% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 5CV.HA View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death Discover 3 US Penny Stocks With Market Caps Over $200M Cerus And 2 Other US Penny Stocks To Watch Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven Is the Options Market Predicting a Spike in CureVac (CVAC) Stock? Is CureVac N.V. (CVAC) the Best German Stock to Buy Now? Where are they now? 4 biotechs that soared then crashed during the pandemic CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ... CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update